Variants in the GH-IGF axis confer susceptibility to lung cancer

Genome Research

Volumn 16, Issue 6, 2006, Pages 693-701

  Rudd, Matthew F ^a   Webb, Emily L ^a   Matakidou, Athena ^a   Sellick, Gabrielle S ^a   Williams, Richard D ^a   Bridle, Helen ^a   Eisen, Tim ^a   Houlston, Richard S ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; GROWTH HORMONE; SOMATOMEDIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DAMAGE; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PENETRANCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOPTOSIS; CASE-CONTROL STUDIES; DNA REPAIR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMAN GROWTH HORMONE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 33744785962     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.5120106     Document Type: Article

References (42)

1. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., et al. 2000. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25: 25-29.
2. Bailey-Wilson, J.E., Amos, C.I., Pinney, S.M., Petersen, G.M., de Andrade, M., Wiest, J.S., Fain, P., Schwartz, A.G., You, M., Franklin, W., et al. 2004. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am. J. Hum. Genet. 75: 460-474.
3. Bell, D.W., Gore, I., Okimoto, R.A., Godin-Heymann, N., Sordella, R., Mulloy, R., Sharma, S.V., Brannigan, B.W., Mohapatra, G., Settleman, J., et al. 2005. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat. Genet. 37: 1315-1316.
4. Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H., and Pollak, M. 1998. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science 279: 563-566.
5. Churchill, G.A. and Doerge, R.W. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
6. Devlin, B. and Roeder, K. 1999. Genomic control for association studies. Biometrics 55: 997-1004.
7. Doll, R. and Peto, R. 1981. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66: 1191-1308.
8. Fearnhead, N.S., Wilding, J.L., Winney, B., Tonks, S., Bartlett, S., Bicknell, D.C., Tomlinson, I.P., Mortensen, N.J., and Bodmer, W.F. 2004. Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc. Natl. Acad. Sci. 101: 15992-15997.
9. Ford, B.N., Ruttan, C.C., Kyle, V.L., Brackley, M.E., and Glickman, B.W. 2000. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis 21: 1977-1981.
10. Garber, M.E., Troyanskaya, O.G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G.D., Perou, C.M., Whyte, R.I., et al. 2001. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. 98: 13784-13789.
11. Hoh, J., Wille, A., and Ott, J. 2001. Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res. 11: 2115-2119.
12. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., De Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. 2002. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609.
13. Hwang, S.J., Cheng, L.S., Lozano, G., Amos, C.I., Gu, X., and Strong, L.C. 2003. Lung cancer risk in germline p53 mutation carriers: Association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum. Genet. 113: 238-243.
14. IARC (International Agency for Research on Cancer). 1986. IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking. IARC, Lyon, France.
15. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., and Hattori, M. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32: D277-D280.
16. Khandwala, H.M., McCutcheon, I.E., Flyvbjerg, A., and Friend, K.E. 2000. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 21: 215-244.
17. Kuschel, B., Auranen, A., McBride, S., Novik, K.L., Antoniou, A., Lipscombe, J.M., Day, N.E., Easton, D.F., Ponder, B.A., Pharoah, P.D., et al. 2002. Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet. 11: 1399-1407.
18. Ma, J., Pollak, M.N., Giovannucci, E., Chan, J.M., Tao, Y., Hennekens, C.H., and Stampfer, M.J. 1999. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91: 620-625.
19. Maglott, D., Ostell, J., Pruitt, K.D., and Tatusova, T. 2005. Entrez Gene: Gene-centered information at NCBI. Nucleic Acids Res. 33: D54-D58.
20. Marchini, J., Donnelly, P., and Cardon, L.R. 2005. Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat. Genet. 37: 413-417.
21. Martin, S.T., Matsubayashi, H., Rogers, C.D., Philips, J., Couch, F.J., Brune, K., Yeo, C.J., Kern, S.E., Hruban, R.H., and Goggins, M. 2005. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene 24: 3652-3656.
22. Matakidou, A., Eisen, T., and Houlston, R.S. 2005. Systematic review of the relationship between family history and lung cancer risk. Br. J. Cancer 93: 825-833.
23. Mohrenweiser, H.W., Xi, T., Vazquez-Matias, J., and Jones, I.M. 2002. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol. Biomarkers Prev. 11: 1054-1064.
24. Moon, J.W., Chang, Y.S., Ahn, C.W., Yoo, K.N., Shin, J.H., Kong, J.H., Kim, Y.S., Chang, J., Kim, S.K., Kim, H.J., et al. 2006. Promoter-202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk. Int. J. Cancer 118: 353-356.
25. Morimatsu, M., Donoho, G., and Hasty, P. 1998. Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to γ-radiation and premature senescence. Cancer Res. 58: 3441-3447.
26. Ng, P.C. and Henikoff, S. 2001. Predicting deleterious amino acid substitutions. Genome Res. 11: 863-874.
27. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108.
28. Ramensky, V., Bork, P., and Sunyaev, S. 2002. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res. 30: 3894-3900.
29. Rudd, M.F., Williams, R.D., Webb, E.L., Schmidt, S., Sellick, G.S., and Houlston, R.S. 2005. The predicted impact of coding single nucleotide polymorphisms database. Cancer Epidemiol. Biomarkers Prev. 14: 2598-2604.
30. Sanders, B.M., Jay, M., Draper, G.J., and Roberts, E.M. 1989. Non-ocular cancer in relatives of retinoblastoma patients. Br. J. Cancer 60: 358-365.
31. Savas, S., Kim, D.Y., Ahmad, M.F., Shariff, M., and Ozcelik, H. 2004. Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol. Biomarkers Prev. 13: 801-807.
32. Schuller, A.G., van Neck, J.W., Beukenholdt, R.W., Zwarthoff, E.C., and Drop, S.L. 1995. IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung. J. Mol. Endocrinol. 14: 349-355.
33. Sherry, S.T., Ward, M.H., Kholodov, M., Baker, L., Phan, L., Smigielski, E.M., and Sirokin, K. 2001. dSNP: The NCBI database of genetic variation. Nucleic Acids Res. 29: 308-311.
34. Stenina, O.I., Ustinov, V., Krukovets, I., Marinic, T., Topol, E.J., and Plow, E.F. 2005. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. FASEB J. 19: 1893-1895.
35. Stephens, M. and Donnelly, P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73: 1162-1169.
36. Stephens, M., Smith, N.J., and Donnelly, P. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978-989.
37. Takemiya, M., Shiraishi, S., Teramoto, T., and Miki, Y. 1987. Bloom's syndrome with porokeratosis of Mibelli and multiple cancers of the skin, lung and colon. Clin. Genet. 31: 35-44.
38. Toniolo, P., Bruning, P.F., Akhmedkhanov, A., Bonfrer, J.M., Koenig, K.L., Lukanova, A., Shore, R.E., and Zeleniuch-Jacquotte, A. 2000. Serum insulin-like growth factor-I and breast cancer. Int. J. Cancer 88: 828-832.
39. Wang, X., Andreassen, P.R., and D'Andrea, A.D. 2004. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24: 5850-5862.
40. Xi, T., Jones, I.M., and Mohrenweiser, H.W. 2004. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83: 970-979.
41. Yamanaka, A., Hirai, T., Ohtake, Y., and Kitagawa, M. 1997. Lung cancer associated with Werner's syndrome: A case report and review of the literature. Jpn. J. Clin. Oncol. 27: 415-418.
42. Yu, H., Spitz, M.R., Mistry, J., Gu, J., Hong, W.K., and Wu, X. 1999. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis. J. Natl. Cancer Inst. 91: 151-156.